標(biāo)題: Titlebook: Innovative Endocrinology of Cancer; Lev M. Berstein,Richard J. Santen Book 2008 The Editor(s) (if applicable) and The Author(s), under exc [打印本頁] 作者: Alacrity 時間: 2025-3-21 19:48
書目名稱Innovative Endocrinology of Cancer影響因子(影響力)
書目名稱Innovative Endocrinology of Cancer影響因子(影響力)學(xué)科排名
書目名稱Innovative Endocrinology of Cancer網(wǎng)絡(luò)公開度
書目名稱Innovative Endocrinology of Cancer網(wǎng)絡(luò)公開度學(xué)科排名
書目名稱Innovative Endocrinology of Cancer被引頻次
書目名稱Innovative Endocrinology of Cancer被引頻次學(xué)科排名
書目名稱Innovative Endocrinology of Cancer年度引用
書目名稱Innovative Endocrinology of Cancer年度引用學(xué)科排名
書目名稱Innovative Endocrinology of Cancer讀者反饋
書目名稱Innovative Endocrinology of Cancer讀者反饋學(xué)科排名
作者: 感情 時間: 2025-3-21 22:57 作者: 變化 時間: 2025-3-22 00:54 作者: 影響深遠(yuǎn) 時間: 2025-3-22 05:02 作者: convert 時間: 2025-3-22 12:35 作者: 可互換 時間: 2025-3-22 15:56
Advances in Experimental Medicine and Biologyhttp://image.papertrans.cn/i/image/467374.jpg作者: auxiliary 時間: 2025-3-22 19:47 作者: 死亡 時間: 2025-3-23 00:36 作者: NEXUS 時間: 2025-3-23 03:31
Svetlana V. Ukraintseva,Konstantin G. Arbeev,Anatoli I. Yashinsertr?ge diskontiert werden und dem materiell der Vergleich mit einem geeigneten Alternativobjekt entspricht: Der Basiszins wird in moderner Betrachtungsweise a978-3-8350-0737-6978-3-8350-9563-2Series ISSN 2627-6380 Series E-ISSN 2627-6399 作者: 貞潔 時間: 2025-3-23 05:31 作者: 條街道往前推 時間: 2025-3-23 10:19 作者: 衣服 時間: 2025-3-23 16:33
Serdar E. Bulun,Evan R. Simpsoninssatz gewichteten Kapitalkosten dar. Demgegenüber wird der Kapitalisierungszinssatz bei Anwendung des Equity- oder Nettoverfahrens, das im Wesentlichen dem in Deutschland vorherrschenden Ertragswertverfahren entspricht, als erwartete bzw. geforderte Eigenkapitalkosten ermittelt, mit denen die den 作者: CESS 時間: 2025-3-23 18:22 作者: 解開 時間: 2025-3-24 01:05
A. Heather Eliasen,Susan E. Hankinsonen den Staatsangeh?rigen zugelassen würde, so w?re damit, wie leicht einzusehen, wieder die Voraussetzung eines Umsatzes gegenw?rtiger gegen künftige Güter, mithin des Zinses, gegeben. Hierin w?re nur eine Best?rkung der Meinung zu finden, welche eben in den individuellen Bedürfnis- und Besitzesvers作者: 場所 時間: 2025-3-24 04:31
Trevor J. Powlesie in Wirklichkeit aber in der bestehenden Erzie- hungspraxis eine ungebrochene Bedeutung behalten haben. Meine Studie befa?t sich jedoch nicht nur mit den Erwartungen, die die Gesellschaft an ihre Mitglieder - und insbesondere an die Kin- der und Heranwachsenden - richtet, sondern sie lenkt die Aufmerk- samk978-3-8100-1359-0978-3-322-99376-2作者: 狂熱語言 時間: 2025-3-24 07:00 作者: altruism 時間: 2025-3-24 12:37
in erster Linie wegen ihrer gemeinsamen sowjetischen Vergangenheit. Sie befinden sich jedoch alle sowohl im Innern als auch in ihren Au?enbeziehungen in einem übergangszustand. Sie werden zu- gleich zunehmend als Teil eines gr??eren Ganzen wahrgenommen - des Kaspischen Beckens in ihrer Eigenschaft 作者: 功多汁水 時間: 2025-3-24 16:28 作者: Phenothiazines 時間: 2025-3-24 22:13
Alison J. Butt,C. Elizabeth Caldon,Catriona M. McNeil,Alexander Swarbrick,Elizabeth A. Musgrove,Robe作者: 肉體 時間: 2025-3-25 02:01 作者: 刪減 時間: 2025-3-25 06:22
Adaptation to Estradiol Deprivation Causes Up-Regulation of Growth Factor Pathways and Hypersensitie molecules involved in the nongenomic signaling process have been identified. Estradiol binds to cell membrance-associated ERα which physically associates with the adaptor protein SHC and induces its phosphorylation. In turn, SHC binds Grb-2 and Sos which results in the rapid activation of MAP kina作者: Ophthalmoscope 時間: 2025-3-25 08:40 作者: 高原 時間: 2025-3-25 13:08 作者: electrolyte 時間: 2025-3-25 16:15
Progesterone Receptor Action:,e/PR and signaling cross-talk in breast cancer models and discuss the potential significance of progestin/PR action in breast cancer biology using examples from both in vitro and in vivo models, as well as limited clinical data. Kinases are emerging as key mediators of PR action. Cross-talk between 作者: Predigest 時間: 2025-3-25 22:37 作者: Capture 時間: 2025-3-26 01:17 作者: 淘氣 時間: 2025-3-26 06:51 作者: 吸引力 時間: 2025-3-26 11:31
Hormonal Heterogeneity of Endometrial Cancer,transition from normal endometrium to a malignant tumor is thought to involve a stepwise accumulation of alterations in cellular mechanisms leading to dysfunctional cell growth. This chapter reviews the current knowledge of the molecular mechanisms commonly associated with development of type I and 作者: 使入迷 時間: 2025-3-26 13:38 作者: Petechiae 時間: 2025-3-26 19:14
Selective Estrogen Modulators as an Anticancer Tool:,distinctly different from estrogen bound ER. The complex recruits protein partners called corepressors to prevent the transcription of estrogen responsive genes. In contrast, at a predominantly estrogenic site coactivators for estrogen action are recruited. Unfortunately at an antiestrogenic site su作者: 檔案 時間: 2025-3-27 00:57
Pharmacogenomics of Endocrine Therapy in Breast Cancer,lt, are relatively unable to catalyze tamoxifen hydroxylation. These same subjects appear to have poorer outcomes when treated with tamoxifen than do CYP2D6 “extensive metabolizers”. These data led the US Food and Drug Administration (FDA) to hold public hearings in 2006 on the inclusion of this pha作者: musicologist 時間: 2025-3-27 04:33 作者: LATE 時間: 2025-3-27 09:10 作者: 痛苦一生 時間: 2025-3-27 09:58
Adaptation to Estradiol Deprivation Causes Up-Regulation of Growth Factor Pathways and Hypersensitieatment with oophorectomy, which substantially lowers estradiol for a prolonged period, respond secondarily to aromatase inhibitors with tumor regression. We have utilized in vitro and in vivo model systems to examine the biologic processes whereby Long Term Estradiol Deprivation (LTED) causes cells作者: 厚臉皮 時間: 2025-3-27 17:11
Role of Endocrine-Genotoxic Switchings in Cancer and Other Human Diseases:,of NCD have raised the concept of ‘normal’ and ‘successful’ aging. The apparent paradox of simultaneous increase with aging of the diseases connected with estrogen deficiency as well as with estrogenic excess can be explained by the existence of the phenomenon of the switching of estrogen effects. A作者: Reclaim 時間: 2025-3-27 21:02 作者: 撕裂皮肉 時間: 2025-3-27 23:51 作者: 仔細(xì)閱讀 時間: 2025-3-28 04:30
Obesity and Diabetes Epidemics:,especially in developing countries and countries undergoing economic transition to a market economy. One consequence of obesity is an increased risk of developing type II diabetes..Overall, there is considerable evidence that overweight and obesity are associated with risk for some of the most commo作者: 中世紀(jì) 時間: 2025-3-28 07:39 作者: LATER 時間: 2025-3-28 11:36 作者: 流動才波動 時間: 2025-3-28 15:56
Proteomics of Cancer of Hormone-Dependent Tissues,sues. Specifically, the introduction of serum PSA measurements into clinical practice has dramatically altered detection and treatment of prostate cancer and serum tumor markers play a critical role in the management of testicular cancer. Serum biomarkers are used for ovarian and pancreatic cancers,作者: 圓桶 時間: 2025-3-28 18:50
Endogenous Hormone Levels and Risk of Breast, Endometrial and Ovarian Cancers:,etween circulating hormones and these cancers varies by both hormone and cancer site, with the most consistent associations observed for sex steroid hormones and breast cancer risk among postmenopausal women. Recently, evidence has begun to accumulate suggesting an important role for endogenous horm作者: Modify 時間: 2025-3-29 00:35
Hormonal Heterogeneity of Endometrial Cancer,ty of cases can be divided into two different types of endometrial cancer based on clinico-pathological and molecular characteristics. Type I is associated with an endocrine milieu of estrogen predominance. These tumors are of endometroid histology and develop from endometrial hyperplasia. They have作者: 不可知論 時間: 2025-3-29 04:43 作者: 熱情贊揚(yáng) 時間: 2025-3-29 09:08
Selective Estrogen Modulators as an Anticancer Tool:,mains the strategy of choice for the treatment and prevention of breast cancer. The selective estrogen receptor modulators (SERMs) are molecules that block estrogen action in breast cancer but can still potentially maintain the beneficial effects of estrogen in other tissues, such as bone and cardio作者: parasite 時間: 2025-3-29 12:33
Pharmacogenomics of Endocrine Therapy in Breast Cancer,in cancer chemotherapy. However, there are large variations among patients in both the therapeutic efficacy and side effects of these drugs. Pharmacogenomics is the study of the role of inheritance in this variation and genetic variation in tamoxifen response represents one of the most striking exam作者: Mingle 時間: 2025-3-29 17:43
Prevention of Breast Cancer Using SERMs,e of breast cancer. Many trials have now been done involving tens of thousands of healthy women evaluating the use of selective oestrogen receptor modulators to reduce the risk of breast cancer in healthy women. Tamoxifen will reduce the early incidence of breast cancer in pre and postmenopausal wom作者: 得意人 時間: 2025-3-29 20:52 作者: 官僚統(tǒng)治 時間: 2025-3-30 03:38 作者: 混沌 時間: 2025-3-30 06:50
Carol A. Lange,Carol A. Sartorius,Hany Abdel-Hafiz,Monique A. Spillman,Kathryn B. Horwitz,Britta M. erfolgt regelm??ig durch Verwendung zukunftsorientierter Verfahren auf Basis des Kapitalwertkalküls oder durch Vergleichsverfahren anhand von Kapitalmarktinformationen. Neben den individuellen Entscheidungskalkülen einzelner Anleger kommt somit den Funktionszusammenh?ngen des Kapitalmarktes eine wic作者: Acumen 時間: 2025-3-30 08:26 作者: CONE 時間: 2025-3-30 14:44 作者: confederacy 時間: 2025-3-30 16:54
A. Heather Eliasen,Susan E. Hankinsonunabh?ngig von Besitzesverschiedenheiten ihre Wirkung ?u?ern, zurückzuführen. Wenn in dieser Hinsicht noch ein Zweifel bestünde, so mu? er schwinden, sobald sich zeigt, da? der Zins auch ohne die Voraussetzung des Sondereigentums, also in einer sozialistisch organisierten Gemeinwirtschaft, nachweisb作者: Iatrogenic 時間: 2025-3-30 21:26
